Page last updated December 8, 2025
ClinicalTrials.gov#: NCT06906627 - Program 1
ClinicalTrials.gov#: NCT06906640 - Program 2
Study Design: Prospective Observational Study
PCORnet Infrastructure: Patient partners or engagement
Principal Investigator: Neha Pagidipati
Institution: Duke Clinical Research Institute
PCORnet® Network Partner: The Coordinating Center for PCORnet®
Funder: Bayer, Boehringer Ingelheim, Lilly
Funding Date: 2024
Study Duration: 2024 – 2026
Participating PCORnet® Clinical Research Networks: INSIGHT, OneFlorida+, PaTH, REACHnet, STAR
Therapeutic Area: Nephrology
Condition: CKD in Diabetes
Status: Recruiting
Research Question(s):
IRIS-CKD is a project focused on improving how doctors check for and treat chronic kidney disease (CKD) in people with type 2 diabetes (T2D). The main goals of the project are to:
- Increase the number of people with type 2 diabetes who get screened for chronic kidney disease.
- Ensure that more patients with both chronic kidney disease and type 2 diabetes receive the treatments recommended by medical guidelines.